Feb 4 (Reuters) - Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development. The ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...

Expert said, the policy encourages industry players to innovate beyond sourcing and consumption, therefore widening ...

The Traits Company, an agricultural biotechnology company headquartered in Research Triangle Park, has announced a strategic collaboration with U.K.-based Wild Bioscience to accelerate the development ...

Find the latest biotech news, including an appointment strengthening the pathway from translational research to new company ...

The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...

The UK government must not rush into a veterinary agreement with Brussels or it risks imposing punitive costs on British ...

At the weekend in Kampala, a piece of news landed that could reshape the future of one of the world’s most neglected diseases. The United States Patent and Trademark Office (USPTO) had accepted a ...

A leading investment expert forecasts a stronger year ahead for CSL shares. Let’s see why. The post 3 reasons to buy CSL ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

Amgen delivered a strong fourth quarter of 2025 and looks well-positioned to absorb the LOEs on Prolia, Xgeva, and Ravicti in ...

If you frequently experience facial redness, irritation and small bumps, you may be dealing with rosacea, a common skin condition that impacts more than 14 million people in the U.S. alone, according ...